Browsing by Author NIKULA T.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2000JRC19825Alpha-Emitting Bismuth Cyclohexybenzyl DTPA Constructs of Recombinant Humanized Anti-CD33 Antibodies: Pharmacokinetics, Bioactivity, Toxicity and Chemistry.NIKULA T.; MC DEVITT M.r.; WU Ch.; KOZAK R.w.; GARMESTANI K.; BRECHBIEL M.w.; CURCIO M.j.; PIPPIN C.g.; TIFFANI-JONES L.; GEERLINGS, SR. M.w., et alArticles in Journals
2000JRC19821Binding of a Bi-213 Labeled Monoclonal Antibody Targeting a Tumor Specific Mutant E-Cadherin in Different Tumor Models.ADAM C.; SCHUHMACHER C.; BECKER K.; HANDSCHUH G.; NIKULA T.; APOSTOLIDIS Christos; FISCHER K.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001JRC22857Cancer Treatment Using Bi-213 and Ac-225 in Radioimmunotherapy.APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliArticles in Journals
2003JRC25722Comparison of the Radiotoxicity of two Alpha-Particle-Emitting Immunoconjugates, Terbium-149 and Bismut-213, Directed against a Tumor-Specific, Exon 9 Deleted (d99) E-Cadherin Adhesion Protein.MIEDERER M.; SEIDL C.; BEYER G.; CHARLTON D.e.; VRANJES-DURIC S.; COMOR J.j.; HUBER Roswitha; NIKULA T.; APOSTOLIDIS Christos; SCHUMACHER C., et alArticles in Journals
2000JRC21181Cytotoxicity of the alpha Emitter 213-Bi Coupled to a Specific Antobody.MIEDERER M.; NIKULA T.; BRANDES K.; HANDSCHUH G.; ADAM C.; SCHUMACHER C.; APOSTOLIDIS Christos; BRECHBIEL M.; SCHMID E.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001JRC21247Lysine Protection against Bismuth Accumulation in the Kidneys when Using 213-Bi-DTPA-MAB.NIKULA T.; APOSTOLIDIS Christos; MOLINET Roger; CARLOS-MARQUEZ R.; BRANDES K.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2001JRC21321Production of Carrier Free Actinium-225/Bismuth-212 from Thorium-229 for alpha-Immunitherapy.APOSTOLIDIS Christos; BETTI Maria; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliContributions to Conferences
2000JRC21180Tumor Binding and Therapeutic Efficacy of 213-Bi Labeled Mutation Specific Monoclonal Antobody in a Human Intraperitoneal Gastric Cancer Model.SENEKOWITSCH-SCHMIDTKE R.; FISCHER K.; SCHUMACHER C.; BECKER I.; BECKER K.; APOSTOLIDIS Christos; NIKULA T.; SCHWAIGER M.Contributions to Conferences